These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23772644)

  • 1. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
    Panagiotidis E; Quigley AM; Pencharz D; Ardeshna K; Syed R; Sajjan R; Bomanji J
    Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
    J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
    Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
    Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
    Yang J; Zhuang H
    Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
    Metser U; Lo G
    Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
    Dierickx D; Tousseyn T; Requilé A; Verscuren R; Sagaert X; Morscio J; Wlodarska I; Herreman A; Kuypers D; Van Cleemput J; Nevens F; Dupont L; Uyttebroeck A; Pirenne J; De Wolf-Peeters C; Verhoef G; Brepoels L; Gheysens O
    Haematologica; 2013 May; 98(5):771-5. PubMed ID: 23065524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
    Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
    Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
    Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performances of F-18 FDG PET or PET/CT for detection of post-transplant lymphoproliferative disorder: a systematic review and meta-analysis.
    Kim DH; Kim SJ
    Nucl Med Commun; 2020 Jun; 41(6):533-539. PubMed ID: 32282633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
    Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
    Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of
    Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
    Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
    Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS
    Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
    Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.